| |
| Please Note - Streaming News is only available to subscribers to the Active Level and above |
|
|
|
E-therapeutics appoints Karl Keegan as CFO
StockMarketWire.com
|
Drug discovery company E-therapeutics said it had appointed Dr Karl Keegan as chief financial officer.
Since 2009, Keegan has held senior executive roles in private and public companies, most recently as CEO of privately held Hox Therapeutics Limited.
At 8:28am: (LON:ETX) eTherapeutics PLC share price was 0p at 12.9p
Story provided by StockMarketWire.com
|
|
|
|
|
|
